FIELD: medicine.
SUBSTANCE: combination therapy schemes are described, including liposomal irinotecan, oxaliplatin and 5-fluorouracil useful in the treatment of stomach cancer, including the treatment of patients with a diagnosis of previously untreated stomach cancer. The combination therapy may include the injection of liposomal irinotecan, oxaliplatin, leucovorin and 5-fluorouracil once every two weeks.
EFFECT: obtaining a combination therapy scheme for the treatment of stomach cancer.
25 cl, 5 ex, 19 tbl, 14 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| METHODS OF TREATING PANCREAS CANCER USING COMBINATION THERAPY INCLUDING LIPOSOMAL IRINOTECAN | 2013 |
|
RU2808427C2 |
| METHODS FOR TREATING PANCREATIC CANCER USING COMBINATION THERAPY COMPRISING LIPOSOMAL IRINOTECAN | 2013 |
|
RU2663450C2 |
| COMBINATION THERAPY USING LIPOSOMAL IRINOTECAN AND PARP INHIBITOR FOR THE TREATMENT OF CANCER | 2016 |
|
RU2760185C2 |
| ADMINISTRATION OF MULTIPLE BOLUSES [6R]-MTHF IN CHEMOTHERAPY BASED ON 5-FLUOROURACIL | 2018 |
|
RU2762596C2 |
| [6R]-MTHF-EFFECTIVE FOLATE ALTERNATIVE IN CHEMOTHERAPY BASED ON 5-FLUOROURACIL | 2018 |
|
RU2763934C2 |
| TREATMENT OF PANCREATIC CANCER | 2018 |
|
RU2792690C2 |
| OPTIMISING INDIVIDUAL DOSES OF 5-FLUORURACIL IN FOLFIRI REGIMEN | 2008 |
|
RU2496499C2 |
| CANCER TREATMENT WITH APPLICATION OF VIRUSES FLUOROPYRIMIDINES AND CAMPTOTHECINS | 2006 |
|
RU2435586C2 |
| METHOD FOR COMBINED TREATMENT OF METASTATIC COLORECTAL CANCER IN PATIENTS WITH RESECTABLE HEPATIC METASTASES AND IN THE ABSENCE OF MUTATIONS IN THE KRAS AND BRAF GENES | 2021 |
|
RU2764955C1 |
| METHOD FOR COMBINED TREATMENT OF OPERABLE STOMACH CANCER WITH A POSITIVE PDL STATUS | 2020 |
|
RU2756870C1 |
